Status:
RECRUITING
Effect of StRess and ExeRcize on the Outcome After Chemo-Radiation
Lead Sponsor:
Maastricht Radiation Oncology
Collaborating Sponsors:
Maastricht University Medical Center
Conditions:
Glioblastoma (GBM)
Eligibility:
All Genders
18+ years
Brief Summary
Glioblastoma (GBM) is a highly malignant, incurable primary brain tumor. Due to the nature of this disease and the extent of the treatment (surgery followed by chemoradiation according to the Stupp tr...
Detailed Description
Psychological stress will be measured using multiple approaches; Physiological measures, stress biomarker and questionnaires. Using this approach, a broad insight in the relationship between stress an...
Eligibility Criteria
Inclusion
- Patients treated with Stupp or Elderly protocol: GBM WHO IV, astrocytoma WHO IV IDHmt, astrocytoma WHO II IDHwt (GBM-like).
- willing to wear the smart watch during the treatment protocol
Exclusion
- younger than 18 years
- not in possession of a smart phone
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05431348
Start Date
June 1 2022
End Date
December 1 2025
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht Radiation Oncology (Maastro)
Maastricht, Limburg, Netherlands, 6229ET